Lexicon Pharmaceuticals, Inc. (LXRX)
2.25
-0.04
(-1.75%)
USD |
NASDAQ |
Aug 31, 16:00
2.255
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Total Long Term Debt (Quarterly) : 57.60M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 57.60M |
| March 31, 2026 | 56.06M |
| December 31, 2025 | 60.60M |
| September 30, 2025 | 63.30M |
| June 30, 2025 | 60.54M |
| March 31, 2025 | 105.22M |
| December 31, 2024 | 104.90M |
| September 30, 2024 | 104.57M |
| June 30, 2024 | 104.38M |
| March 31, 2024 | 104.95M |
| December 31, 2023 | 104.77M |
| September 30, 2023 | 104.71M |
| June 30, 2023 | 104.25M |
| March 31, 2023 | 54.30M |
| December 31, 2022 | 54.00M |
| September 30, 2022 | 29.22M |
| June 30, 2022 | 24.63M |
| March 31, 2022 | 24.58M |
| December 31, 2021 | 1.19M |
| September 30, 2021 | 13.17M |
| June 30, 2021 | 13.30M |
| March 31, 2021 | 13.38M |
| December 31, 2020 | 12.26M |
| September 30, 2020 | 20.87M |
| June 30, 2020 | 245.82M |
| Date | Value |
|---|---|
| March 31, 2020 | 246.20M |
| December 31, 2019 | 246.28M |
| September 30, 2019 | 246.34M |
| June 30, 2019 | 246.39M |
| March 31, 2019 | 246.46M |
| December 31, 2018 | 245.00M |
| September 30, 2018 | 244.94M |
| June 30, 2018 | 245.09M |
| March 31, 2018 | 245.40M |
| December 31, 2017 | 245.67M |
| September 30, 2017 | 100.14M |
| June 30, 2017 | 100.54M |
| March 31, 2017 | 101.02M |
| December 31, 2016 | 101.45M |
| September 30, 2016 | 101.83M |
| June 30, 2016 | 102.20M |
| March 31, 2016 | 102.57M |
| December 31, 2015 | 105.81M |
| September 30, 2015 | 106.29M |
| June 30, 2015 | 106.76M |
| March 31, 2015 | 107.21M |
| December 31, 2014 | 107.67M |
| September 30, 2014 | 20.61M |
| June 30, 2014 | 21.04M |
| March 31, 2014 | 21.46M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Viatris, Inc. | 13.51B |
| Pfizer Inc. | 63.10B |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |
| Veru, Inc. | 1.908M |